Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
DOI: https://doi.org/10.2147/IDR.S412951
2023-06-16
Infection and Drug Resistance
Abstract:Aynias Seid, 1, 2 Yilak Girma, 3 Ayenesh Abebe, 3 Eseye Dereb, 3 Meseret Kassa, 3 Nega Berhane 2 1 Department of Biology, College of Natural and Computational Science, Debre-Tabor University, Debre-Tabor, Ethiopia; 2 Department of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia; 3 TB Culture Laboratory, University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia Correspondence: Aynias Seid, Email Background: Multidrug-resistant tuberculosis (MDR-TB) has continued to be a serious public health threat and significantly challenges global TB control and prevention efforts, where the TB/HIV co-infection epidemic makes the situation much worse. The aim of the study was to determine the determinant factors associated with patterns of MDR-TB among pulmonary TB patients in the Northwest Amhara, Ethiopia. Methods: A hospital-based cross-sectional study was conducted from May 2022 to February 2023 in the Northwest Amhara, Ethiopia. Data on the participants' socio-demographics and clinical characteristics were obtained using a pre-tested checklist. Phenotypic susceptibility testing to first-line anti-TB drugs was performed on 180 isolates by automated BD BACTEC MGIT 960 system. Logistic regression analysis was performed to determine the association of risk factors with patterns of MDR-TB. A p-value ≤ 0.05 was considered statistically significant. Results: The overall proportion of TB with HIV co-infected cases was 19.8% (50/252). Culture positivity was confirmed in 203/252 (80.6%) of sputum samples. Among 168 isolates, the DST showed that 119 (70.8%) isolates were pan-susceptible to all first-line drugs and prevalence of any resistance to first-line drugs was 49,168 (29.2%). Among the resistant isolates, 28 (16.7%) were any mono-resistance and 12 (7.1%) were determined to be resistant to MDR-TB. TB with a previous TB treatment (aOR = 6.73, 95% CI: 1.78– 25.47, p = 0.005) and HIV co-infected (aOR = 0.252, 95% CI: 0.73– 0.875, p = 0.03) were significantly associated with MDR-TB. Conclusion: Higher prevalence of TB and MDR-TB was examined among TB patients in the study area. In the study, history of previous TB treatment was the strongest risk factor MDR-TB infection followed by TB with HIV co-infected cases. Therefore, there is a need of strengthening TB control and prevention programs to reduce the increase of TB incidence, further emergence and transmission of a public health threat of MDR-TB cases. Keywords: drug resistance, MDR-TB, prevalence, risk factors, TB/HIV co-infection Tuberculosis (TB) is a communicable contagious disease caused by a single infectious agent, the Mycobacterium tuberculosis ( M. tuberculosis ) complex strain. It is the most prevalent opportunistic bacterial infection. According to the World Health Organization (WHO) Global TB Report 2022, there were an estimated 10.6 million (9.9–11 million) cases of TB worldwide in 2021, of which 6.7% were TB/HIV co-infected cases, an increase of 4.5% from the estimates of 10.1 million (9.5–10.7 million) in 2020; 1.6 million deaths (1.4 million among HIV-negative individuals and 187, 000 among HIV-positive individuals); and close to 141, 953 multidrug-resistant (MDR-TB) cases (defined as TB resistant to the two most effective first-line anti-TB drugs called isoniazid (INH) and rifampicin (RIF)) in 2021, 1 an increase by 6.4% in 2020. 2 The highest incidence of TB cases in 2021 was among South-East Asia (45%) WHO area followed by Africa (23%). Ethiopia is one of the 30 global lists of high-burden countries for TB and HIV-associated TB, but transitioned out of MDR-TB list. 1 The current effective global TB control approach is based on an early diagnosis and sufficient treatment regimens using anti-TB medications globally. 1 Nonetheless, the emergency and spread of drug resistance such as MDR-TB remains one of the ongoing problems in the global TB control campaign. 3 The extent of occurrence of drug-resistant TB including MDR-TB and its burden varies significantly from country to country and from region to region but is high in resource-poor countries. 4 The emergency of MDR-TB arises from spontaneous chromosomal resistance-conferring mutations at a low frequency, and they can be transmitted directly from one person to another by resistant bacteria that possess these variants. 5 Besides, the majority of drug-resistant strains are also acquired by environmental exposure due to physician error including selection pressure brought on by inappropriate anti-TB drug prescriptions, poor diagnostic capabilities or insufficient infrastructure in h -Abstract Truncated-
pharmacology & pharmacy,infectious diseases